期刊文献+

四维彩超联合促甲状腺激素在诊断甲状腺癌中的临床价值 被引量:6

Value of four-dimensional color Doppler ultrasound combined with thyroid stimulating hormonein diagnosis of thyroid cancer
暂未订购
导出
摘要 目的评价高频彩超联合促甲状腺激素在甲状腺癌诊断中的价值,进一步提高诊断准确率,减少误、漏诊率。方法分析2010年1月~2011年12月在我院就诊的甲状腺癌患者45例,将上述患者按照随机对照原则分为A组(25例)和B组(20例),其中A组患者术前进行彩超诊断,B组患者术前进行四维彩超联合促甲状腺激素诊断,对两组患者的诊断率进行比较。结果 A组患者彩超诊断甲状腺癌14例(56.0%),未能确定良恶性6例(24.0%),误诊为良性病变5例(20.0%)。B组患者四维彩超联合促甲状腺激素诊断甲状腺癌18例(90.0%),未能确定良恶性1例(5.0%),误诊为良性病变1例(5.0%)。两组患者之间诊断率比较,差异具有统计学意义(χ2=6.252,P<0.05)。结论甲状腺癌的超声表现具有一定的特征性,应用四维彩超联合促甲状腺激素诊断甲状腺癌具有重要的临床价值。 Objective To evaluate high frequency ultrasonography combined with TSH in thyroid cancer diagnosis to further improve the accuracy of diagnosis,reduce error and the rate of missed diagnosis.Methods 45 cases patients with thyroid cancer from January 2010 to December 2011 in our hospital were analyzed.The patients according to the random and control principle divided into group A(n = 25) and group B(n = 20).Group A were diagnosed by color Doppler ultrasound before operation,while group B were diagnosed by preoperative four-dimensional color Doppler ultrasound combined with TSH diagnosis.Then compared the diagnosis rate of two groups of patients.Results In the A group,patients with color Doppler ultrasound in diagnosis of thyroid carcinoma were 14 cases(56%).Failing to identify benign and malignant were 6 cases(24%).5 cases were misdiagnosed as benign lesion(20%).The patients in the B group four-dimensional color Doppler ultrasound combined with TSH in diagnosis of thyroid carcinoma were 18 cases(90%).Failing to identify benign and malignant was 1 case(5%).1 case was misdiagnosed as benign lesion(5%).There was statistical difference between two groups(χ2 = 6.252,P 〈0.05).Conclusion Thyroid carcinoma with ultrasonography has certain characteristics.Four-dimensional color Doppler ultrasound combined with TSH in diagnosis of thyroid cancer has important clinical value.
出处 《中国医药导报》 CAS 2012年第21期98-99,共2页 China Medical Herald
基金 广东省东莞市科技计划医疗卫生类科研项目(项目编号:201110515000040)
关键词 四维彩超 促甲状腺激素 甲状腺癌 诊断 Four-dimensional color Doppler ultrasound TSH Thyroid Cancer Diagniosis
  • 相关文献

参考文献10

  • 1中国甲状腺疾病诊治指南——甲状腺结节[J].中华内科杂志,2008,47(10):867-868. 被引量:345
  • 2Little JW. Thyroid disorders Part IE: neoplastic thyroid disease [J]. OralSurg Oral Med Oral Pathol Oral Radiol Endod, 2006,102 (3) : 275-280.
  • 3Senchenkov A,Staren ED. Ultrasound in head and neck sui^ery :thyroid,parathyroid,and cervical lymph nodes [J]. Surg Clin North Am,2004,84(4):973-1000.
  • 4Aigner F,Mitterberger M ,Rehder P,et al. Status of transrectal ultrasoundimaging of the prostate [J]. J Endourol,20I0, 24(5) :685-691.
  • 5Megan EH,Daniel JR,Glen EL,et al. Higher serum thyioid stimulatinghormone level in thyroid nodule patients is associated with greater risksof differentiated thyroid cancer and advanced tumor stage [J]. J ClinEndocrinol Metab, 2008,93(3):809-814.
  • 6郑冬梅,鹿宁,陈青,张海清,姜秀云,管庆波,赵家军.甲状腺结节的临床分析[J].山东大学学报(医学版),2009,47(8):14-17. 被引量:32
  • 7袁媛,赵明.600例甲状腺结节病理分析及恶性甲状腺结节特征探讨[J].医学研究生学报,2009,22(10):1069-1072. 被引量:20
  • 8史良凤,关海霞,李玉姝,李佳,单忠艳,滕卫平.术前血清促甲状腺素水平与甲状腺结节良恶性关系的研究[J].中华内分泌代谢杂志,2010,26(3):213-214. 被引量:60
  • 9Hoelting T.Goretzki PE,Duh QY. Follicular thyroid cancer cells:model of metastatic tumor in vitro [J]. Oncol Rep,2001,8(1) :3-8.
  • 10Kebebew E,Klark OH. Differentiated thyroid cancer:complete rationalapproach [J]. World J Surg,2000,24(8) :942-951.

二级参考文献33

  • 1张雷,李文雅,金梅.甲状腺手术中冷冻切片检查的价值[J].临床耳鼻咽喉头颈外科杂志,2007,21(7):299-301. 被引量:15
  • 2杭剑萍,孟东,高其忠,李励琦,谢智惠.结节型桥本病388例外科治疗分析[J].中华内分泌代谢杂志,2007,23(3):246-248. 被引量:8
  • 3Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am, 2007, 36:707-735.
  • 4AACE/AME Task Force Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nedules. Endocr Pract, 2006,12:63-102.
  • 5Filetti S, Durante C, Torlontano M. Nonsurgical approaches to the management of thyroid nodules. Nat Clin Praet Endoerinol Metab, 2006, 2:384-394.
  • 6Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2007, 92 :S1-47.
  • 7Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2006, 16: 109-142.
  • 8Josefson J,Zimmerman D.Thyroid nodules and cancers in children[J].Pediatr Endocrinol Rev,2008,6(1):14-23.
  • 9Polyzos SA,Kita M,Efstathiadou Z,et al.Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules[J].J Cancer Res Clin Oncol,2008,134(9):953-960.
  • 10Haymart MR,Repplinger DJ,Leverson GE,et al.Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage[J].J Clin Endocrinol Metab,2008,93(3):809-814.

共引文献438

同被引文献24

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部